Abstract
The development of efficient ways to deliver large molecules such as peptides, proteins, and nucleic acids across the blood-brain barrier (BBB) is crucial to future therapeutic strategies for treatment of central nervous system (CNS) disorders. The principal approach to deliver macromolecules across the BBB is the development of chimeric peptides (1). Ligands to various receptors that undergo transcytosis across brain capillary endothelium and are essential for physiological transport of proteins, including transferrin, insulin growth factor, and low-density lipoprotein, into the brain are used as vectors to deliver drugs or therapeutic peptides chemically linked to the ligand (1,2). This process is known as receptor-mediated endocytosis/transcytosis. An anti-transferrin receptor antibody (OX-26), for example, has been used to deliver endorphin, vasoactive intestinal peptide, and brain-derived neurotrophic factor (1), as well as oligonucleotides and plasmid deoxyribonucleic acid (DNA) (2) into the brain parenchyma. Further development of this approach requires rapid discovery of other suitable receptors/antigens expressed on human BBB endothelium that undergo transcytosis upon ligand binding.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bickel, U., Yoshikawa, T., and Pardridge, W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Deliv. Rev. 46, 247–279.
Shi, N., and Pardridge, W. M. (2000) Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. USA 97, 7567–7572.
Hoogenboom, H. R., de Bruine, A. P., Hufton, S. E., Hoet, R. M., Arends, J. W., and Roovers, R. C. (1998) Antibody phage display technology and its applications. Immunotechnology 4, 1–20.
Nilsson, F., Tarli, L., Viti, F., and Neri, D. (2000) The use of phage display for the development of tumor targeting agents. Adv. Drug Del. Rev. 43, 165–196.
Muyldermans, S., and Lauwereys, M. (1999) Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J. Mol. Recog. 12, 131–140.
Tanha, J., Dubuc, G., Hirama, T., Narang, S. A., and MacKenzie, C. R. (2002) Selection by phage display of llama conventional VH fragments with heavy chain antibody VHH properties. J. Immunol. Meth. 263, 97–109.
Stanimirovic, D., Morley, P., Ball, R., Hamel, E., Mealing, G., and Durkin, J. P. (1996) Angiotensin II-induced fluid phase endocytosis in human cerebromicrovascular endothelial cells is regulated by the inositol-hosphate signaling pathway. J. Cell. Physiol. 169, 455–467.
Yong, V. W., Tejada-Berges, T., Goodyear, C. G., Antel, J. P., and Yong, F. P. (1992) Differential proliferative responses of human and mouse astrocytes to gamma interferon. Glia 6, 269–280.
Narang, S. A., Yao, F.-L., Michniewicz, J. J., Dubuc, G., Phipps, J., and Somorjai, R. L. (1987) Hierarchical strategy for protein folding and design: synthesis and expression of T4 lysozyme gene and two putative folding mutants. Protein Eng. 1, 481–485.
Muruganandam, A., Herx, L. M., Monette, R., Durkin, J. P., and Stanimirovic, D. B. (1997) Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J. 13, 1187–1197.
Sanger, F., Nicklen, S., and Coulson, A. R. (1977) DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463–5467.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Tung, W. L., and Chow, K. C. (1995) A modified medium for efficient electrotransformation of E. coli. Trends Genet. 11, 128, 129.
Anand, N. N., Dubuc, G., Phipps, J., et al. (1991) Synthesis and expression in Escherichia coli of cistronic DNA encoding an antibody fragment specific for a Salmonella serotype B O-antigen. Gene 100, 39–44.
MacKenzie, C. R., Sharma, V., Brummell, D., et al. (1994) Effect of C lambda-C kappa domain switching on Fab activity and yield in Escherichia coli: synthesis and expression of genes encoding two anti-carbohydrate Fabs. Biotechnology NY 12, 390–395.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
Muruganandam, A., Tanha, J., Narang, S., and Stanimirovic, D. (2001) Selection of phage-displayed llama single-domain antibodies that transmigrate human blood-brain barrier endothelium. FASEB J. 16, 240–242.
Pardridge, W. M., Triguero, D., Yang, J., and Cancilla, P.A. (1990) Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J. Pharmacol. Exp. Therap. 253, 884–891.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Tanha, J., Muruganandam, A., Stanimirovic, D. (2003). Phage Display Technology for Identifying Specific Antigens on Brain Endothelial Cells. In: Nag, S. (eds) The Blood-Brain Barrier. Methods in Molecular Medicine™, vol 89. Humana Press. https://doi.org/10.1385/1-59259-419-0:435
Download citation
DOI: https://doi.org/10.1385/1-59259-419-0:435
Publisher Name: Humana Press
Print ISBN: 978-1-58829-073-1
Online ISBN: 978-1-59259-419-1
eBook Packages: Springer Protocols